[How far should we go in reducing the length of antibiotic therapy for community-acquired pneumonia?]

Rev Pneumol Clin. 2005 Apr;61(2):61-6. doi: 10.1016/s0761-8417(05)84791-1.
[Article in French]
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology
  • Drug Administration Schedule
  • Drug Resistance, Microbial
  • Humans
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Bacterial / microbiology

Substances

  • Anti-Bacterial Agents